Higher Order Chromatin and Genetic Risk for Alzheimer's Disease
Higher Order Chromatin and Genetic Risk for Alzheimer's Disease
批准号:
8937445
负责人:
Panagiotis Roussos
金额:
$66.81万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-09-01 至 2020-04-30
关键词:
AffectAgeAllelesAlzheimer&aposs DiseaseAntibodiesArchitectureAstrocytesAutopsyBrainBrain DiseasesBrain regionBypassCatalogingCatalogsCell LineChIP-seqChromatinChromatin StructureChromosome MappingChromosomesDNADataData SetDiseaseDrug FormulationsElderlyElementsEnhancersFluorescence-Activated Cell SortingFunctional disorderFutureGene ExpressionGene Expression ProfileGene Expression RegulationGene FrequencyGenerationsGenesGeneticGenetic Enhancer ElementGenetic PolymorphismGenetic RiskGenetic VariationGenomeGenotypeHistocompatibility TestingHumanIntercistronic RegionLinkLinkage DisequilibriumLysineMapsMicrogliaMinorMolecularMolecular ConformationNervous System PhysiologyNeuronsNucleic Acid Regulatory SequencesOutcomeParahippocampal GyrusPathologyPopulationPositioning AttributeQuantitative Trait LociRegulatory ElementResolutionRiskRoleSiteSpecimenSuperior temporal gyrusTissuesTranscription Initiation SiteTranscriptional RegulationUnited States National Institutes of HealthUntranslated RNAVariantarea striatabasebrain cellbrain tissuecell typechromatin immunoprecipitationcombinatorialcostdesigndisorder riskepigenetic regulationepigenomeepigenomicsgenetic variantgenome wide association studygenome-widehistone modificationhuman genome sequencinginnovationinsightpromoterpublic health relevancerisk varianttranscriptome sequencing
中文摘要
描述(申请人提供):阿尔茨海默氏症(AD)的遗传学研究进展迅速。在基因间、内含子和其他非编码序列中发现了越来越多的与风险相关的多态性和变异体。然而,设计可检验的假说来阐明这类与疾病相关的非编码DNA的潜在功能一直是一个重大挑战。这些序列中的许多被认为具有调节功能,包括与线性基因组上被许多千碱基散布的DNA隔开的转录起始点(TS)物理上相互作用的长程增强子元件。我们将首先生成组织和细胞群体(神经元、星形胶质细胞和小胶质细胞)中与AD病理生理相关的开放染色质和增强子序列的全面注释图。然后,我们将利用来自脑组织中两个大型、多区域RNAseq项目的高分辨率表达数量性状基因座(EQTL)图,并识别AD相关的非编码区,这些非编码区位于用组合组蛋白修饰签名标记的调节区内,组蛋白修饰签名指示活性增强子和TSS长距离相互作用的统计(EQTL)证据。然后,我们将使用神经表观遗传学中的创新方法,包括染色体构象捕捉(3C)来绘制人类死后脑组织中长程增强子-启动子相互作用的图谱。这里提出的多维方法提供了一个路线图,可以解开人类基因组中巨大但在很大程度上未被探索的非编码序列的神经功能。
英文摘要
DESCRIPTION (provided by applicant): The genetics of Alzheimer's Dementia (AD) is advancing at rapid pace. An increasing number of risk- associated polymorphisms and variants are found in intergenic, intronic and other non-coding sequence. However, it has been a major challenge to design testable hypotheses to elucidate the potential function of such types of disease-associated non-coding DNA. Many of these sequences are thought to exert regulatory functions, including longe range enhancer elements physically interacting with transcription start sites (TSS) separated on the linear genome by many kilobases of interspersed DNA. We will first generate a comprehensive annotation map of open chromatin and enhancer sequences in tissue and cellular populations (neurons, astrocytes and microglia) that are relevant to the pathophysiology of AD. We will then leverage high resolution expression quantitative trait loci (eQTL) maps from two large, multiregional RNAseq projects in brain tissue and identify AD associated noncoding regions that are positioned within regulatory regions tagged with combinatorial histone modification signatures indicative of active enhancers and statistical (eQTL) evidence for long range TSS interactions. We then will employ innovative approaches in neuroepigenetics, including chromosome conformation capture (3C) to map long range enhancer-promoter interactions in human brain postmortem tissue. The multidimensional approach presented here provides a roadmap to unravel the neurological functions of the vast but in brain largely unexplored non-coding sequences of the human genome.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Towards an integrated analytics solution to creating a spatially-resolved single-cell multi-omics brain atlas
-
批准号:10724843
-
项目类别:
-
资助金额:$257.67万
-
财政年份:2023
-
负责人:Panagiotis Roussos
-
依托单位:
Multiethnic genomic epigenomic and transcriptomic fine-mapping and functional validation analysis of schizophrenia and bipolar disorder risk loci
-
批准号:10541205
-
项目类别:
-
资助金额:$100.21万
-
财政年份:2021
-
负责人:Panagiotis Roussos
-
依托单位:
Multiethnic genomic epigenomic and transcriptomic fine-mapping and functional validation analysis of schizophrenia and bipolar disorder risk loci
-
批准号:10116719
-
项目类别:
-
资助金额:$85.13万
-
财政年份:2021
-
负责人:Panagiotis Roussos
-
依托单位:
Multiethnic genomic epigenomic and transcriptomic fine-mapping and functional validation analysis of schizophrenia and bipolar disorder risk loci
-
批准号:10323051
-
项目类别:
-
资助金额:$81.55万
-
财政年份:2021
-
负责人:Panagiotis Roussos
-
依托单位:
Large-scale transcriptome and epigenome association analysis across multiple traits
-
批准号:10584192
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:Panagiotis Roussos
-
依托单位:
Large-scale transcriptome and epigenome association analysis across multiple traits
-
批准号:10436137
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:Panagiotis Roussos
-
依托单位:
Large-scale transcriptome and epigenome association analysis across multiple traits
-
批准号:10512763
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:Panagiotis Roussos
-
依托单位:
Large-scale transcriptome and epigenome association analysis across multiple traits
-
批准号:9483393
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:Panagiotis Roussos
-
依托单位:
Risk genetic variants and cis regulation of gene expression in Bipolar Disorder
-
批准号:9082676
-
项目类别:
-
资助金额:$85.99万
-
财政年份:2016
-
负责人:Panagiotis Roussos
-
依托单位:
Higher Order Chromatin and Genetic Risk for Alzheimer's Disease
-
批准号:10317310
-
项目类别:
-
资助金额:$166.54万
-
财政年份:2015
-
负责人:Panagiotis Roussos
-
依托单位:
Higher Order Chromatin and Genetic Risk for Alzheimer's Disease
-
批准号:9134035
-
项目类别:
-
资助金额:$69.0万
-
财政年份:2015
-
负责人:Panagiotis Roussos
-
依托单位:
Higher Order Chromatin and Genetic Risk for Alzheimer's Disease
-
批准号:10640179
-
项目类别:
-
资助金额:$164.02万
-
财政年份:2015
-
负责人:Panagiotis Roussos
-
依托单位:
Dissecting cis regulation of gene expression in schizophrenia.
-
批准号:10555180
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:Panagiotis Roussos
-
依托单位:
Dissecting Cis Regulation of Gene Expression in Schizophrenia
-
批准号:8635057
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:Panagiotis Roussos
-
依托单位:
Dissecting cis regulation of gene expression in schizophrenia.
-
批准号:10082418
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:Panagiotis Roussos
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: